Want to join the conversation?
$LLY and AstraZeneca said they received U.S. Food and Drug Administration (FDA) Fast Track designation for development program in Alzheimer's disease for AZD3293, oral beta secretase cleaving enzyme (BACE) inhibitor now in phase 3 clinical trials. $LLY and AstraZeneca also announced planned initiation of second phase 3 trial for AZD3293.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.
$VZ strikes again. After a depressing quarter, Verizon has jumped into action by launching its ultrafast competitor to Google Fiber - FiOS Gigabit Connection.